Purpose: This study is to present a new quantitative analysis tool for evaluation of prostate IMRT (intensity modulated radiation therapy) plans. Methods and Materials: Based on retrospective analysis of 33 prostate patients (18 with intact prostate and 15 with prostatectomy) for a total of 84 acceptable treatment plans, we developed a new concept, dosimetric plan index (DPI), which integrates the measures of dose conformity, target coverage and OAR (organ at risk) overdose. DPI is defined as: [formula omitted], where CI (conformity index) is defined as the ratio of the volume of a PTV (planned target volume) inside the prescribed IDL (isodose line) to the volume enclosed by the IDL; TC (target coverage index) is defined as the ratio of the volume of a PTV inside the prescribed IDL to the volume of the PTV; DGI (dose gradient index of an OAR) is defined as e−d/λOAR , d is the distance between 95% and 50% IDL, λOAR is the nominal distance that can be commonly achieved in a specified disease site, and it equals to 1 cm for prostate IMRT plans with rectum as an OAR. Results: The target volume and the volume of rectum enclosed by 50% IDL vary dramatically for different acceptable plans. The mean COSI (critical organ scoring index) of these plans is 0.66 ± 0.18 for intact prostate plans and 0.54 ± 0.14 for post‐prostatectomy plans. However, those plans share a common merit that their DPIs are in a much narrower range, 0.63 ± 0.02 for intact prostate plans and 0.59 ± 0.02 for post‐prostatectomy plans. Conclusion: The DPI is a new comprehensive treatment plan scoring tool, accounting for the information derived both from DVH (dose volume histogram) and isodose distribution. It can assist physician/planner to evaluate and optimize treatment plans for target coverage and normal tissue sparing.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging